Goldman Sachs downgraded Zealand Pharma to Buy from Conviction Buy. The firm removed the shares from its European Conviction List as part of its monthly “Directors’ Cut” update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>